Antihypertensive therapy in acute cerebral haemorrhage

Trends in Anaesthesia and Critical Care

Volumn 3, Issue 1, 2013, Pages 31-36

  De Robertis, Edoardo ^a   Romano, Giovanni Marco ^a   Zito Marinosci, Geremia ^a   Servillo, Giuseppe ^a   Tufano, Rosalba ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Blood pressure; Hypertension; ICH growth; Intracerebral haemorrhage; Outcome

Indexed keywords

ANTIHYPERTENSIVE AGENT; CLEVIDIPINE; ENALAPRIL; ESMOLOL; GLYCERYL TRINITRATE; HYDRALAZINE; INDAPAMIDE PLUS PERINDOPRIL; LABETALOL; NICARDIPINE; NITROPRUSSIDE SODIUM; PERINDOPRIL;

ANTIHYPERTENSIVE THERAPY; BLOOD PRESSURE REGULATION; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; BRAIN PERFUSION; CLINICAL EFFECTIVENESS; HEALTH CARE COST; HEMATOMA; HYPERTENSION; PATHOPHYSIOLOGY; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

EID: 84873200289     PISSN: 22108440     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tacc.2012.12.001     Document Type: Review

References (70)

1. Rosamond W., Flegal K., Furie K., Go A., Greenlund K., Haase N., et al. Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2008, 117(4):e25-146.
2. Taylor T.N., Davis P.H., Torner J.C., Holmes J., Meyer J.W., Jacobson M.F. Lifetime cost of stroke in the United States. Stroke 1996, 27(9):1459-1466.
3. Andersen K.K., Olsen T.S., Dehlendorff C., Kammersgaard L.P. Hemorrhagic and ischemic strokes compared: stroke severity, mortality, and risk factors. Stroke 2009, 40(6):2068-2072.
4. Qureshi A.I., Tuhrim S., Broderick J.P., Batjer H.H., Hondo H., Hanley D.F. Spontaneous intracerebral hemorrhage. N Engl J Med 2001, 344(19):1450-1460.
5. Wityk R.J., Caplan L.R. Hypertensive intracerebral hemorrhage. Epidemiology and clinical pathology. Neurosurg Clin N Am 1992, 3(3):521-532.
6. Willmot M., Leonardi-Bee J., Bath P.M.W. High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 2004, 43(1):18-24.
7. Feigin V.L., Lawes C.M.M., Bennett D.A., Anderson C.S. Stroke epidemiology: a review of population-based studies of incidence, prevalence, and case-fatality in the late 20th century. Lancet Neurol 2003, 2(1):43-53.
8. Feigin V.L., Lawes C.M.M., Bennett D.A., Barker-Collo S.L., Parag V. Worldwide stroke incidence and early case fatality reported in 56 population-based studies: a systematic review. Lancet Neurol 2009, 8(4):355-369.
9. van Asch C.J., Luitse M.J., Rinkel G.J., van der Tweel I., Algra A., Klijn C.J. Incidence, case fatality, and functional outcome of intracerebral haemorrhage over time, according to age, sex, and ethnic origin: a systematic review and meta-analysis. Lancet Neurol 2010, 9(2):167-176.
10. Thrift A.G., McNeil J.J., Forbes A., Donnan G.A. Risk factors for cerebral hemorrhage in the era of well-controlled hypertension. Melbourne Risk Factor Study (MERFS) Group. Stroke 1996, 27(11):2020-2025.
11. Arakawa S., Saku Y., Ibayashi S., Nagao T., Fujishima M. Blood pressure control and recurrence of hypertensive brain hemorrhage. Stroke 1998, 29(9):1806-1809.
12. O'Donnell M.J., Xavier D., Liu L., Zhang H., Chin S.L., Rao-Melacini P., et al. Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries (the INTERSTROKE study): a case-control study. Lancet 2010, 376(9735):112-123.
13. Ariesen M.J., Claus S.P., Rinkel G.J.E., Algra A. Risk factors for intracerebral hemorrhage in the general population: a systematic review. Stroke 2003, 34(8):2060-2065.
14. Woo D., Haverbusch M., Sekar P., Kissela B., Khoury J., Schneider A., et al. Effect of untreated hypertension on hemorrhagic stroke. Stroke 2004, 35(7):1703-1708.
15. Thrift A.G., McNeil J.J., Forbes A., Donnan G.A. Three important subgroups of hypertensive persons at greater risk of intracerebral hemorrhage. Melbourne Risk Factor Study Group. Hypertension 1998, 31(6):1223-1229.
16. Auer R.N., Sutherland G.R. Primary intracerebral hemorrhage: pathophysiology. Can J Neurol Sci 2005, 32(Suppl. 2):S3-S12.
17. Lovelock C.E., Molyneux A.J., Rothwell P.M. Change in incidence and aetiology of intracerebral haemorrhage in Oxfordshire, UK, between 1981 and 2006: a population-based study. Lancet Neurol 2007, 6(6):487-493.
18. SHEP-Cooperative-Research-Group Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the systolic hypertension in the elderly program (SHEP). SHEP Cooperative Research Group. J Am Med Assoc 1991, 265(24):3255-3264.
19. PROGRESS-Collaborative-Group Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. Lancet 2001, 358(9287):1033-1041.
20. Mayer S.A., Rincon F. Treatment of intracerebral haemorrhage. Lancet Neurol 2005, 4(10):662-672.
21. Brott T., Broderick J., Kothari R., Barsan W., Tomsick T., Sauerbeck L., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28(1):1-5.
22. Davis S.M., Broderick J., Hennerici M., Brun N.C., Diringer M.N., Mayer S.A., et al. Hematoma growth is a determinant of mortality and poor outcome after intracerebral hemorrhage. Neurology 2006, 66(8):1175-1181.
23. Xi G., Keep R.F., Hoff J.T. Mechanisms of brain injury after intracerebral haemorrhage. Lancet Neurol 2006, 5(1):53-63.
24. Hemphill J.C., Bonovich D.C., Besmertis L., Manley G.T., Johnston S.C. The ICH score: a simple, reliable grading scale for intracerebral hemorrhage. Stroke 2001, 32(4):891-897.
25. Balami J.S., Buchan A.M. Complications of intracerebral haemorrhage. Lancet Neurol 2012, 11(1):101-118.
26. Wartenberg K.E., Mayer S.A. Reducing the risk of ICH enlargement. J Neurol Sci 2007, 261(1-2):99-107.
27. Broderick J.P., Diringer M.N., Hill M.D., Brun N.C., Mayer S.A., Steiner T., et al. Determinants of intracerebral hemorrhage growth an exploratory analysis. Stroke 2007, 38(3):1072-1075.
28. Kazui S., Minematsu K., Yamamoto H., Sawada T., Yamaguchi T. Predisposing factors to enlargement of spontaneous intracerebral hematoma. Stroke 1997, 28(12):2370-2375.
29. Barras C.D., Tress B.M., Christensen S., MacGregor L., Collins M., Desmond P.M., et al. Density and shape as CT predictors of intracerebral hemorrhage growth. Stroke 2009, 40(4):1325-1331.
30. Demchuk A.M., Dowlatshahi D., Rodriguez-Luna D., Molina C.A., Blas Y.S., Dzialowski I., et al. Prediction of haematoma growth and outcome in patients with intracerebral haemorrhage using the CT-angiography spot sign (PREDICT): a prospective observational study. Lancet Neurol 2012, 11(4):307-314.
31. Leira R., Dávalos A., Silva Y., Gil-Peralta A., Tejada J., Garcia M., et al. Early neurologic deterioration in intracerebral hemorrhage: predictors and associated factors. Neurology 2004, 63(3):461-467.
32. Silva Y., Leira R., Tejada J., Lainez J.M., Castillo J., Dávalos A. Molecular signatures of vascular injury are associated with early growth of intracerebral hemorrhage. Stroke 2005, 36(1):86-91.
33. Naidech A.M., Jovanovic B., Liebling S., Garg R.K., Bassin S.L., Bendok B.R., et al. Reduced platelet activity is associated with early clot growth and worse 3-month outcome after intracerebral hemorrhage. Stroke 2009, 40(7):2398-2401.
34. Anderson C.S., Huang Y., Wang J.G., Arima H., Neal B., Peng B., et al. Intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT): a randomised pilot trial. Lancet Neurol 2008, 7(5):391-399.
35. Qureshi A.I., Palesch Y.Y., Martin R., Novitzke J., Cruz-Flores S., Aa Ehtisham, et al. Effect of systolic blood pressure reduction on hematoma expansion, perihematomal edema, and 3-month outcome among patients with intracerebral hemorrhage: results from the antihypertensive treatment of acute cerebral hemorrhage study. Arch Neurol 2010, 67(5):570-576.
36. Antihypertensive Treatment of Acute Cerebral Hemorrhage (ATACH) investigators Antihypertensive treatment of acute cerebral hemorrhage. Crit Care Med 2010, 38(2):637-648.
37. Steiner T., Bösel J. Options to restrict hematoma expansion after spontaneous intracerebral hemorrhage. Stroke 2010, 41(2):402-409.
38. Ohwaki K., Yano E., Nagashima H., Hirata M., Nakagomi T., Tamura A. Blood pressure management in acute intracerebral hemorrhage: relationship between elevated blood pressure and hematoma enlargement. Stroke 2004, 35(6):1364-1367.
39. Martí-Fàbregas J., Martínez-Ramírez S., Martínez-Corral M., Díaz-Manera J., Querol L., Suárez-Calvet M., et al. Blood pressure is not associated with haematoma enlargement in acute intracerebral haemorrhage. Eur J Neurol 2008, 15(10):1085-1090.
40. Jauch E.C., Lindsell C.J., Adeoye O., Khoury J., Barsan W., Broderick J., et al. Lack of evidence for an association between hemodynamic variables and hematoma growth in spontaneous intracerebral hemorrhage. Stroke 2006, 37(8):2061-2065.
41. Butcher K.S., Baird T., MacGregor L., Desmond P., Tress B., Davis S. Perihematomal edema in primary intracerebral hemorrhage is plasma derived. Stroke 2004, 35(8):1879-1885.
42. Matsuoka H., Hamada R. Role of thrombin in CNS damage associated with intracerebral haemorrhage: opportunity for pharmacological intervention?. CNS Drugs 2002, 16(8):509-516.
43. Hua Y., Keep R.F., Hoff J.T., Xi G. Brain injury after intracerebral hemorrhage: the role of thrombin and iron. Stroke 2007, 38(2 Suppl.):759-762.
44. Arima H., Wang J.G., Huang Y., Heeley E., Skulina C., Parsons M.W., et al. Significance of perihematomal edema in acute intracerebral hemorrhage: the INTERACT trial. Neurology 2009, 73(23):1963-1968.
45. Anderson C.S., Huang Y., Arima H., Heeley E., Skulina C., Parsons M.W., et al. Effects of early intensive blood pressure-lowering treatment on the growth of hematoma and perihematomal edema in acute intracerebral hemorrhage: the intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT). Stroke 2010, 41(2):307-312.
46. Gebel J.M., Jauch E.C., Brott T.G., Khoury J., Sauerbeck L., Salisbury S., et al. Relative edema volume is a predictor of outcome in patients with hyperacute spontaneous intracerebral hemorrhage. Stroke 2002, 33(11):2636-2641.
47. Vemmos K.N., Tsivgoulis G., Spengos K., Zakopoulos N., Synetos A., Kotsis V., et al. Association between 24-h blood pressure monitoring variables and brain oedema in patients with hyperacute stroke. J Hypertens 2003, 21(11):2167-2173.
48. Wallace J.D., Levy L.L. Blood pressure after stroke. J Am Med Assoc 1981, 246(19):2177-2180.
49. Qureshi A.I. Acute hypertensive response in patients with stroke: pathophysiology and management. Circulation 2008, 118(2):176-187.
50. Qureshi A.I., Ezzeddine M.A., Nasar A., Suri M.F.K., Kirmani J.F., Hussein H., et al. Prevalence of elevated blood pressure in 563,704 adult patients presenting to the emergency department with stroke in the United States. Am J Emerg Med 2007, 25(1):32-38.
51. Zhang Y., Reilly K.H., Tong W., Xu T., Chen J., Bazzano L.A., et al. Blood pressure and clinical outcome among patients with acute stroke in Inner Mongolia, China. J Hypertens 2008, 26(7):1446-1452.
52. Dandapani B.K., Suzuki S., Kelley R.E., Reyes-Iglesias Y., Duncan R.C. Relation between blood pressure and outcome in intracerebral hemorrhage. Stroke 1995, 26(1):21-24.
53. Okumura K., Ohya Y., Maehara A., Wakugami K., Iseki K., Takishita S. Effects of blood pressure levels on case fatality after acute stroke. J Hypertens 2005, 23(6):1217-1223.
54. Vemmos K.N., Tsivgoulis G., Spengos K., Zakopoulos N., Synetos A., Manios E., et al. U-shaped relationship between mortality and admission blood pressure in patients with acute stroke. J Intern Med 2004, 255(2):257-265.
55. Fogelholm R., Avikainen S., Murros K. Prognostic value and determinants of first-day mean arterial pressure in spontaneous supratentorial intracerebral hemorrhage. Stroke 1997, 28(7):1396-1400.
56. Mendelow A.D., Gregson B.A., Fernandes H.M., Murray G.D., Teasdale G.M., Hope D.T., et al. Early surgery versus initial conservative treatment in patients with spontaneous supratentorial intracerebral haematomas in the international surgical trial in intracerebral haemorrhage (STICH): a randomised trial. Lancet 2005, 365(9457):387-397.
57. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. Recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2005, 352(8):777-785.
58. Mayer S.A., Brun N.C., Begtrup K., Broderick J., Davis S., Diringer M.N., et al. Efficacy and safety of recombinant activated factor VII for acute intracerebral hemorrhage. N Engl J Med 2008, 358(20):2127-2137.
59. Mayer S.A., Davis S.M., Skolnick B.E., Brun N.C., Begtrup K., Broderick J.P., et al. Can a subset of intracerebral hemorrhage patients benefit from hemostatic therapy with recombinant activated factor VII?. Stroke 2009, 40(3):833-840.
60. Morgenstern L.B., Hemphill J.C., Anderson C., Becker K., Broderick J.P., Connolly E.S., et al. Guidelines for the management of spontaneous intracerebral hemorrhage: a guideline for healthcare professionals from the American Heart Association/American Stroke Association. Stroke 2010, 41(9):2108-2129.
61. Siddique M.S., Fernandes H.M., Wooldridge T.D., Fenwick J.D., Slomka P., Mendelow A.D. Reversible ischemia around intracerebral hemorrhage: a single-photon emission computerized tomography study. J Neurosurg 2002, 96(4):736-741.
62. Schellinger P.D., Fiebach J.B., Hoffmann K., Becker K., Orakcioglu B., Kollmar R., et al. Stroke MRI in intracerebral hemorrhage: is there a perihemorrhagic penumbra?. Stroke 2003, 34(7):1674-1679.
63. Zazulia A.R., Diringer M.N., Videen T.O., Adams R.E., Yundt K., Aiyagari V., et al. Hypoperfusion without ischemia surrounding acute intracerebral hemorrhage. J Cereb Blood Flow Metab 2001, 21(7):804-810.
64. Kim-Han J.S., Kopp S.J., Dugan L.L., Diringer M.N. Perihematomal mitochondrial dysfunction after intracerebral hemorrhage. Stroke 2006, 37(10):2457-2462.
65. Powers W.J., Zazulia A.R., Videen T.O., Adams R.E., Yundt K.D., Aiyagari V., et al. Autoregulation of cerebral blood flow surrounding acute (6 to 22 hours) intracerebral hemorrhage. Neurology 2001, 57(1):18-24.
66. Koch S., Romano J.G., Forteza A.M., Otero C.M., Rabinstein A.A. Rapid blood pressure reduction in acute intracerebral hemorrhage: feasibility and safety. Neurocrit Care 2008, 8(3):316-321.
67. Qureshi A.I., Palesch Y.Y. Antihypertensive treatment of acute cerebral hemorrhage (ATACH) II: design, methods, and rationale. Neurocrit Care 2011, 15(3):559-576.
68. Delcourt C., Huang Y., Wang J., Heeley E., Lindley R., Stapf C., et al. The second (main) phase of an open, randomised, multicentre study to investigate the effectiveness of an intensive blood pressure reduction in acute cerebral haemorrhage trial (INTERACT2). Int J Stroke 2010, 5(2):110-116.
69. Broderick J., Connolly S., Feldmann E., Hanley D., Kase C., Krieger D., et al. Guidelines for the management of spontaneous intracerebral hemorrhage in adults: 2007 update: a guideline from the American Heart Association/American stroke Association Stroke Council, High Blood Pressure Research Council, and the Quality of Care and Outcomes in Research Interdisciplinary Working Group. Stroke 2007, 38(6):2001-2023.
70. Nguyen H.M., Ma K., Pham D.Q. Clevidipine for the treatment of severe hypertension in adults. Clin Ther 2010, 32(1):11-23.